AbbVie and Elawa Farm Foundation, both based in Lake Forest, passed their FDA inspections with clean marks this spring. But one Lake County pharmaceutical manufacturer did not.
Baxter Healthcare Corporation's Round Lake plant is the only facility among seven inspected countywide in the second quarter of 2026 to receive an "Official Action Indicated" classification, the FDA's most serious finding, according to the Lake County Gazette and the agency's public inspection database. The designation means inspectors identified significant regulatory violations requiring mandatory corrective action at the plant, which employs more than 400 workers across three shifts.
Six passed. One didn't.
What OAI means for Baxter
The FDA uses three inspection classifications. "No Action Indicated" means no problems were found. "Voluntary Action Indicated" means objectionable conditions exist but don't require regulatory intervention. OAI, the most severe, means the agency recommends regulatory or administrative action.
Potential consequences include a formal warning letter, import alerts that could block products from entering the U.S. market, product recalls, delays to pending drug approvals and injunctions. Baxter must conduct a root cause analysis and submit a corrective action plan to the FDA.
No warning letter tied to the April 2 inspection has appeared in public records as of Aug. 10. The specific violations cited by inspectors have not been publicly released, and Baxter Healthcare Corporation has not issued a public statement regarding the finding.
The Round Lake facility
Baxter's plant at 25212 IL-120 in Round Lake spans 355,300 square feet and manufactures more than 50 pharmaceutical products, including Cephalosporin, Non-Cephalosporin and Penicillin lines that reach an estimated 40 million patients globally. It is one of 19 plants in Baxter International's worldwide network.
Separate recall in July
In a separate action, Baxter issued a voluntary nationwide recall on July 24 of one lot of Cefazolin in Dextrose Injection (Lot LD175708) after particulate matter identified as cardboard was found in the solution. The FDA's recall notice stated the defect carries "a reasonable probability of causing pulmonary emboli, occlusions of other blood vessels, and/or phlebitis." Baxter said it had received no reports of adverse events as of the recall date.
Whether the recall is connected to the April inspection finding is not publicly known.
Lake Forest companies pass clean
AbbVie, headquartered in Lake Forest, received two separate clean results on April 27: one in the Drugs sector and one in the Veterinary sector. Elawa Farm Foundation, the nonprofit at 1401 Middlefork Drive in Lake Forest, received a clean result in the Food and Cosmetics sector on April 20.
The remaining inspected companies were AED Battery Exchange (April 9), Heinz Orchard (April 23), Jacobson Family Farms (April 20) and Sterigenics U.S. (June 4). All received No Action Indicated results.
Fewer inspections countywide
The seven second-quarter inspections represent a 46.2% drop from the first quarter of 2026, when 13 companies received 14 inspections. The FDA updates its inspection database weekly with final classifications at datadashboard.fda.gov.
